1. Home
  2. ULBI vs KRRO Comparison

ULBI vs KRRO Comparison

Compare ULBI & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ultralife Corporation

ULBI

Ultralife Corporation

HOLD

Current Price

$6.48

Market Cap

97.6M

Sector

Miscellaneous

ML Signal

HOLD

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$10.74

Market Cap

109.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ULBI
KRRO
Founded
1990
2014
Country
United States
United States
Employees
N/A
87
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.6M
109.7M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
ULBI
KRRO
Price
$6.48
$10.74
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$34.80
AVG Volume (30 Days)
65.5K
207.0K
Earning Date
03-10-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
1166.67
N/A
EPS
0.09
N/A
Revenue
$164,456,000.00
$6,392,000.00
Revenue This Year
$20.00
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$74.56
N/A
Revenue Growth
3.66
181.46
52 Week Low
$4.07
$5.20
52 Week High
$9.51
$55.89

Technical Indicators

Market Signals
Indicator
ULBI
KRRO
Relative Strength Index (RSI) 56.09 43.60
Support Level $6.35 $10.55
Resistance Level $7.24 $14.96
Average True Range (ATR) 0.46 0.89
MACD 0.12 -0.11
Stochastic Oscillator 66.52 6.50

Price Performance

Historical Comparison
ULBI
KRRO

About ULBI Ultralife Corporation

Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: